Browsing Tag
bladder cancer
17 posts
Johnson & Johnson fortifies urologic oncology pipeline with compelling Inlexzo results
Johnson & Johnson's new data show Inlexzo delivers strong one-year disease-free survival. Find out how it could shift bladder cancer care.
Can reimbursement unlock the next wave of office-based cancer care? What ZUSDURI and CMS J-codes reveal about oncology’s outpatient shift
Can J-codes like ZUSDURI’s drive the next wave of office-based cancer care? Find out why 2026 could be a turning point in outpatient oncology.
Will UroGen Pharma’s reimbursement tailwind in 2026 turn ZUSDURI into a category-defining cancer therapy?
UroGen Pharma sets $1B peak sales goal for ZUSDURI as permanent J-code from 2026 is expected to drive widespread adoption in outpatient urology settings.
Padcev and Keytruda combo cuts bladder cancer recurrence risk by 60% in pivotal Phase 3 win
Discover how the Padcev and Keytruda combination achieved unprecedented survival gains in bladder cancer — read our expert take.
Why Japan’s review of Ferring’s bladder cancer gene therapy candidate could reshape urology
Discover how Ferring’s gene therapy nadofaragene firadenovec could transform NMIBC treatment in Japan after PMDA NDA acceptance.
Photocure’s blue light cystoscopy demonstrates 38% recurrence reduction in BRAVO study
Photocure ASA, a bladder cancer company, has unveiled new clinical evidence demonstrating the advantages of blue light cystoscopy…
Blue Light cystoscopy enhances bladder cancer detection and upstaging at ASCO GU 2025
Bladder cancer remains one of the most prevalent and recurrent malignancies worldwide, requiring ongoing advancements in diagnostic and…
Unilabs partners with Pangea to bring advanced bladder cancer test to Switzerland
Pangea Laboratory and Unilabs have announced a strategic collaboration to introduce the Bladder CARE Assay, an advanced non-invasive…
Japan’s MHLW grants priority review for PADCEV and KEYTRUDA combo in urothelial cancer
In a significant development in the fight against urothelial cancer, Astellas Pharma Inc. announced that Japan’s Ministry of…
Advancing bladder cancer treatment: EMA scrutinizes Astellas-Pfizer’s innovative therapy
A groundbreaking development in bladder cancer treatment is on the horizon as Astellas Pharma Inc. and Pfizer Inc.…